Sep 22, 2026 · 7 min
Alibaba, On Holdings rise as Quest faces Medicare pressure
Alibaba and ON Climb; Quest Slides
The episode shows how chip competition, athletic-brand expansion, and proposed healthcare reimbursement cuts are moving shares in different directions.
- 1Alibaba is developing a data-center chip to challenge Nvidia while U.S. export controls complicate production.
- 2On Holdings projects high-teens sales growth and is expanding from tennis into golf and soccer.
- 3Quest Diagnostics falls as proposed Medicare laboratory payment rates point to lower industry reimbursement.
Don't miss
Alibaba’s chip ambitions meet the practical constraint of producing advanced technology under U.S. export controls.
The brief
The roundup opens with Thor Industries, where stronger-than-expected sales could not offset thinner margins; the RV maker expects a relatively flat market ahead.
Alibaba is introducing a data-center chip aimed at Nvidia, but U.S. export controls create production challenges that could limit its competitive reach.
On Holdings forecasts high-teens sales growth and is moving beyond tennis into golf and soccer, including a partnership with Kylian Mbappé.
Quest Diagnostics shares decline after preliminary Medicare rates imply lower laboratory-service reimbursement, with final rates expected later in the year.
Taken together, the movers reflect three distinct market tests: technological access, brand expansion, and policy-driven pressure on healthcare revenue.
What was said on this episode
5 statements · 2 positive · 2 negative · 1 neutral
Thor Industries expects a relatively flat RV market in 2027 versus 2026.
“the company says it expects a relatively flat environment in 2027 compared to 2026”
Listen at 1:18
Alibaba says its new data-center chip triples predecessor performance.
“Alibaba is calling this China's most powerful chip and says it triples performance of its predecessor”
Listen at 2:03
On Holdings forecasts high-teens sales growth under its three-year plan.
“On Holdings is forecasting sales growth in high teens as part of its new 3-year plan”
Listen at 3:17
Preliminary Medicare lab payment rates are estimated to save $1 billion.
“They say it will align with the private sector and estimate a $1 billion savings according to the statement.”
Listen at 4:19
David Westenberg sees current Medicare lab rates as slightly worse than prior company guidance.
“Piper Sandler analyst David Westenberg sees the current rates cut slightly worse than what the companies assumed in previous guidance.”
Listen at 4:36
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Featuring
Mentioned
Thor Industries
Nvidia Corporation
Taiwan Semiconductor Manufacturing Company Limited (TSMC)
Bloomberg Audio StudiosListen to the full episode and explore every guest, topic, and moment on PodLume.